{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_057187.3:c.6055G>A",
          "cDNA Change": {
            "transcript": "NM_057187.3",
            "ref": "G",
            "alt": "A",
            "position": "6055"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "2019"
          },
          "Description in input context": "LRRK2 G2019S is a common mutation associated with Parkinson's disease."
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005144"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "The experiment was conducted using HEK293 cells overexpressing the LRRK2 G2019S variant."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_057187.3:c.6055G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Overexpression of LRRK2 G2019S in HEK293 cells showed increased kinase activity compared to wild-type LRRK2."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not described in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not described in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Kinase activity within 10% of wild-type levels.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Kinase activity exceeding 20% of wild-type levels.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Kinase Activity Assay",
      "Material used": {
        "Material Source": "Patients Derived Material",
        "Material Name": "Patient-derived fibroblasts",
        "Description": "Functional assays were conducted using patient-derived fibroblasts with LRRK2 G2019S."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_057187.3:c.6055G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Patient-derived fibroblasts with LRRK2 G2019S exhibited elevated kinase activity compared to fibroblasts with wild-type LRRK2."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not described in the literature."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not described in the literature."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not described in the literature."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not described in the literature."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Kinase activity within 10% of wild-type levels.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Kinase activity exceeding 20% of wild-type levels.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}